Investment
Features
FeesSafety
Academy
More
Pluang+

StarkWare CEO proposes 4% annual Bitcoin inflation to replace 21M cap due to lost coins

Market News
08 Jul 2026
Crypto Briefing
View Source
Neutral
pluang ai news

Eli Ben-Sasson, CEO of StarkWare, suggests replacing Bitcoin's 21 million supply cap with a 4% annual issuance to address the problem of lost private keys reducing usable Bitcoin. He argues this would maintain miner incentives and network security as block subsidies shrink, contrasting Bitcoin's fixed supply with Ethereum's flexible monetary policy. The proposal faces strong opposition from Bitcoin purists who see any supply change as a threat. Investors should watch how transaction fees evolve as subsidies decline, which will influence Bitcoin's future monetary policy.

More News

Abeona Therapeutics' price target cut to $15 after Q2 revenue miss and operational issues with Zevaskyn therapy.

Abeona Therapeutics' price target cut to $15 after Q2 revenue miss and operational issues with Zevaskyn therapy.

Industrial Alliance Securities lowered Abeona Therapeutics' price target from $20 to $15 following a 14% stock drop after the company reported Q2 revenues of $11.4 million, missing analyst expectations. The company faces operational challenges with i...

Analyst Insights
Bearish
40 minutes ago
Inovio advances DNA medicine pipeline with FDA review of INO-3107 and $18.3M funding secured

Inovio advances DNA medicine pipeline with FDA review of INO-3107 and $18.3M funding secured

Inovio Pharmaceuticals is progressing its DNA medicine pipeline with its lead candidate INO-3107 for Recurrent Respiratory Papillomatosis under FDA accelerated review, targeting a decision by October 30, 2026. The company raised $18.3 million in fund...

Market News
Bullish
51 minutes ago
Life360 director Morin Brit sells 15,582 shares for $1 million

Life360 director Morin Brit sells 15,582 shares for $1 million

Morin Brit, a director at Life360, sold 15,582 shares of the company, generating $1 million from the transaction. This sale may indicate a personal financial decision or portfolio adjustment by the director. Investors might watch for any further insi...

Market News
Bearish
1 hour ago
AbCellera's stock jumps after successful menopause drug trial and CFO insider buying.

AbCellera's stock jumps after successful menopause drug trial and CFO insider buying.

AbCellera Biologics announced positive Phase 2 trial results for its experimental menopause drug ABCL635, which significantly reduced hot flash frequency by 83%. The stock surged 33.19% to a 52-week high of $11.32, boosting the company's market cap t...

Market News
Bullish
1 hour ago
TOMI Environmental posts 118% revenue growth and beats EPS estimates despite ongoing losses

TOMI Environmental posts 118% revenue growth and beats EPS estimates despite ongoing losses

TOMI Environmental Solutions reported a 118% year-over-year revenue increase to $2.25 million, surpassing analyst estimates of $1.84 million. The company also beat EPS expectations with a loss of $0.05 per share, better than the anticipated loss of $...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App